Drug Trial Radar · NCT05029050
Dexmedetomidine or Clonidine Infusion for Prevention of Delirium After Open Heart Surgery
Last checked: Nov 19, 2026Latest source record: Nov 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
900
Planned (sponsor's estimate)
Start
Jan 17, 2022
Primary completion
Jul 31, 2026
Study completion Jan 2027
Sponsor
- Lead sponsor
- Oslo University HospitalAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Haukeland University Hospital; University Hospital of North Norway; UMC Utrecht; Sahlgrenska University Hospital; St. Olavs Hospital
- First posted
- Aug 31, 2021
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Prevention
- FDA-regulated drug
- No
- Who can join
- All sexes, from 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A parallel-group treatment, five-centre, participant and investigator masked, three-arm study to assess the safety and effectiveness of dexmedetomidine or clonidine infusion compared to placebo for the prevention of delirium and cognitive decline in male and female participants aged 70+ scheduled for open heart surgery.
Conditions
- Delirium
- Cognitive Decline
- Frailty
Interventions
DexmedetomidineDrug
Continous intravenous infusion
ClonidineDrug
Continous intravenous infusion
NatriumchloridDrug
Continous intravenous infusion NaCl
Primary outcomes
What the sponsor says the trial is designed to measure.
- Postoperative deliriumTime frame: Up to 7 days
Locations
5 sites in 1 country. Site status is shown where the registry gives one.
Haukeland University Hospital
Bergen, Norway
Oslo University Hospital Rikshospitalet
Oslo, Norway
Oslo University Hospital Ullevål
Oslo, Norway
University Hospital of North Norway
Tromsø, Norway
St Olav University Hospital
Trondheim, Norway
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.